The Hidden Risks In The Africa–Mexico–USA–Australia Meat Chain

A sixteen-year-old Australian boy ate beef sausages during a camping trip and died.

Jeremy Webb’s death in June 2022 has now been formally attributed to mammalian meat allergy, also known as alpha-gal syndrome—a potentially fatal allergy associated with tick bites that can cause the human immune system to react violently to beef, lamb, pork, gelatine and other mammalian products.

In February 2026, the NSW Deputy State Coroner concluded that Jeremy suffered fatal anaphylaxis caused by mammalian meat allergy, triggering an acute asthma attack. He became the first Australian whose death was officially confirmed as resulting from this condition.

It is a heartbreaking case. It should also trigger serious questions about the sudden prominence of an allergy that effectively prevents people from eating meat.

• Not ridicule.
• Not censorship.
• Not the usual demand that the public stop asking questions.
• An independent investigation.

An Allergy That Turns Meat Into A Threat

Mammalian meat allergy is unusual because it is not considered a conventional childhood food allergy.

It can develop after a tick bite.

The immune system becomes sensitised to galactose-alpha-1,3-galactose—commonly called alpha-gal—a carbohydrate found in most non-primate mammals. A person who previously ate meat without difficulty can begin suffering hives, gastrointestinal distress, swelling, breathing difficulties or anaphylaxis several hours after consuming mammalian meat or products containing alpha-gal.

CSIRO now says preliminary surveillance indicates reported Australian cases have increased by approximately 22 per cent annually since 2020. Researchers are also investigating a possible association between alpha-gal antibodies and cardiovascular disease.

That is not a minor dietary inconvenience.

It is an emerging biological condition capable of removing meat from a person’s diet, complicating the use of medicines and medical products containing mammalian ingredients, and potentially exposing sufferers to life-threatening reactions.

At the very least, the public deserves to know why it is apparently increasing.

Gates-Funded Tick Engineering

In May 2023, British biotechnology company Oxitec announced that the Bill & Melinda Gates Foundation had committed US$4.8 million to begin developing what the company calls a “Friendly” solution targeting the Asian blue cattle tick, Rhipicephalus microplus.

Oxitec describes this tick as one of the world’s most destructive cattle parasites. It spreads livestock diseases, costs farmers billions of dollars and has developed resistance to many chemical pesticides.

The company’s proposed solution involves biological or genetic technology intended to suppress or control tick populations.

Oxitec says its feasibility work showed that developing the technology was achievable and could eventually benefit cattle farmers.

That is the company’s position.

The unanswered question is what work has been undertaken, where it has occurred, what organisms have been handled, what genetic changes have been explored and what independent monitoring has been conducted.

Claims have circulated that Gates-funded Oxitec cattle-tick work has not included field trials on Australian cattle in Australia.

However, people claiming knowledge of operations in Central Queensland have alleged that research or trial-related activity was conducted under strict confidentiality arrangements, with scientists and technical field staff required to sign confidentiality agreements.

Those allegations have not been established by the publicly available evidence reviewed for this article.

But that is precisely why they should not simply be waved away.

They should be investigated.

The Mosquito Partnership Australians Were Told Not To Worry About

Oxitec, CSIRO and Gates-linked funding have already been connected through biotechnology programs involving mosquitoes.

Oxitec Australia—a partnership between Oxitec and CSIRO—planned to release genetically modified mosquitoes in Queensland. The proposed technology involved releasing engineered male mosquitoes carrying a self-limiting gene intended to prevent female offspring from surviving.

The application was withdrawn in December 2025 following public criticism and concern from scientists and health specialists.

CSIRO stated that the withdrawal was related to the company’s early financial position and regulatory costs—not safety concerns.

Critics nevertheless raised questions about ecological consequences, the proposed commercial distribution of genetically modified mosquito eggs and the fact that the imported mosquito strain had not been tested against Australian mosquito genetics before the original release proposal.

A whistleblower has reportedly alleged that live malaria virus was detected in a trial area and that the program was subsequently discontinued.

But an allegation involving genetically modified insects, infectious organisms and environmental release cannot responsibly be dismissed through public relations statements alone. It requires transparent records, independent laboratory evidence and scrutiny conducted outside the organisations financially or institutionally connected to the project.

The Timeline Does Not Prove Causation—But It Demands Transparency

There is currently no publicly established evidence proving that Oxitec’s cattle-tick research caused mammalian meat allergy in Australia or South Africa.

That must be stated clearly.

Mammalian meat allergy was observed in Australia decades before Oxitec announced its Gates-funded cattle-tick program. Australian clinicians were investigating associations between tick bites and meat allergy well before the recent biotechnology projects discussed here.

Alpha-gal syndrome has also been reported across numerous countries and associated with several different tick species.

Those facts weaken any simplistic claim that the condition was newly created by one modern research program.

They do not, however, eliminate legitimate questions about whether environmental manipulation, laboratory breeding, genetic technologies, altered tick populations, introduced organisms or experimental pest-control programs could affect the prevalence, geographical distribution or biological behaviour of tick-associated disease.

The relevant question is not merely:

“Did mammalian meat allergy exist before this research?”

The more important questions are:

• Could experimental programs make it more common?
• Could they alter tick populations or behaviour?
• Could laboratory or field activities spread particular tick species, biological material or immune-sensitising agents?
• Were Australian communities adequately informed?
• Were nearby human and animal populations medically monitored?
• Were unexpected events recorded?
• Were confidentiality agreements used to prevent public scrutiny?
• Were all adverse findings disclosed?

Until those questions are answered through independent access to project records, environmental samples, trial protocols and personnel testimony, institutional assurances are not enough.

A Conflict Of Public Trust

The Bill & Melinda Gates Foundation funds global programs involving agriculture, food systems, vaccines, biotechnology, mosquitoes, livestock and population health.

Oxitec develops genetically engineered insects and other biological pest-control technologies.

CSIRO is both Australia’s national science agency and a commercial research partner.

These organisations may argue that their work is intended to improve public health, protect agriculture and reduce dependence on pesticides.

But good intentions do not remove risk.

Prestigious names do not replace accountability.

And scientific expertise does not grant any institution the right to conduct environmentally consequential research behind confidentiality agreements while expecting the public to accept every official assurance without question.

When the same organisations operate across agriculture, insects, biotechnology and human health, apparent conflicts and possible unintended consequences must be investigated—not mocked out of existence.

Who Benefits From A Population That Cannot Eat Meat?

Mammalian meat allergy produces an outcome that happens to align remarkably well with an increasingly aggressive political and commercial movement encouraging populations to reduce or eliminate livestock consumption.

A person with alpha-gal syndrome does not merely choose a plant-based diet.

Their immune system can make that decision for them.

That does not prove the condition was deliberately manufactured to discourage meat consumption.

But it explains why the public is entitled to examine possible connections between biotechnology programs, insect manipulation, agricultural policy and a growing medical condition that makes mammalian meat dangerous.

• The consequences are too significant to ignore.
• Meat producers lose customers.
• Patients lose dietary freedom.
• Families face hidden exposure risks.
• Medical treatments become more complicated.
• Alternative-protein industries gain a larger potential market.
• Governments obtain another argument for reducing livestock production.
• And biotechnology companies receive more funding to manage biological problems using more biotechnology.

That circular system deserves scrutiny.

The Public Deserves Records, Not Reassurances

Australians should be given a complete public accounting of all Oxitec, CSIRO and Gates Foundation-supported research involving ticks, mosquitoes and related biological-control technologies conducted in or connected to Australia.

That accounting should include:

• All Australian laboratory and field locations.
• All imported insect and tick strains.
• All genetically modified or selectively bred organisms.
• All funding agreements.
• All project partners and subcontractors.
• All environmental-release applications.
• All adverse-event reports.
• All infectious-agent testing.
• All containment failures.
• All human and animal monitoring data.
• All confidentiality agreements signed by researchers and field staff.
• All communications concerning discontinued or paused programs.

The investigation must be independent of CSIRO, Oxitec, the Gates Foundation and agencies that previously approved or partnered in the work.

The death of Jeremy Webb demonstrates that mammalian meat allergy is not theoretical.

It can kill.

No evidence currently proves that it was manufactured in a laboratory or deliberately released to stop humans eating meat. Claiming that as an established fact would go beyond the available evidence.

But pretending there are no legitimate questions would be equally irresponsible.

When powerful organisations manipulate insects and parasites, conduct confidential biological research and propose environmental releases, the burden should not be placed on ordinary Australians to prove that something went wrong.

The burden belongs to the organisations conducting the experiments.

• Open the records.
• Release the data.
• Protect the whistleblowers.
• Test the environments.
• Investigate the timelines.

And stop treating public suspicion as the problem when institutional secrecy is what created it.